MAPT and Alzheimer disease: This finding is related to the fact that t-tau reflects the massive neuronal cell loss associated with prion diseases; p-tau (as a marker of hyperphosphorylated tau associated with neurofibrillary pathology) is thus normal in prion diseases but increased in AD and to a lesser extent in other tauopathies49–52.